INCR Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for InterCure Ltd (INCR.O) is 0.00, compared to its 5-year average forward P/E of -0.38. For a more detailed relative valuation and DCF analysis to assess InterCure Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.38

Current PE

0.00

Overvalued PE

0.79

Undervalued PE

-1.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.30

Current EV/EBITDA

0.94

Overvalued EV/EBITDA

12.49

Undervalued EV/EBITDA

-11.90

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

1.42

Current PS

0.00

Overvalued PS

2.50

Undervalued PS

0.35

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

INCR News & Events

Events Timeline

No data

News

8.0

2025-12-19Benzinga

Trump's Marijuana Reclassification Expected to Propel This Cannabis ETF: Significant Momentum Increase

8.5

2025-09-19Benzinga

InterCure Joins High-End US Cannabis Market Through ISHI Agreement

8.5

2025-09-19Newsfilter

InterCure Reveals Strategic Purchase of ISHI, Gaining Access to Top U.S. Cannabis Technology and Brands

People Also Watch

Frequently Asked Questions

What is InterCure Ltd (INCR) stock price today?

The current price of INCR is 1.02 USD — it has increased 6.25 % in the last trading day.

What is InterCure Ltd (INCR)'s business?

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

What is the price predicton of INCR Stock?

Wall Street analysts forecast INCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INCR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is InterCure Ltd (INCR)'s revenue for the last quarter?

InterCure Ltd revenue for the last quarter amounts to 102.44M USD, increased 7.52 % YoY.

What is InterCure Ltd (INCR)'s earnings per share (EPS) for the last quarter?

InterCure Ltd. EPS for the last quarter amounts to 0.10 USD, decreased -70.59 % YoY.

What changes have occurred in the market's expectations for InterCure Ltd (INCR)'s fundamentals?

The market is revising No Change the revenue expectations for INCR for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -36.25%.

How many employees does InterCure Ltd (INCR). have?

InterCure Ltd (INCR) has 280 emplpoyees as of January 10 2026.

What is InterCure Ltd (INCR) market cap?

Today INCR has the market capitalization of 55.77M USD.